Search Results - "Kupstytė, Nora"

Artificial intelligence for automated evaluation of aortic measurements in 2D echocardiography: Feasibility, accuracy, and reproducibility by Karužas, Arnas, Balčiūnas, Justinas, Fukson, Mark, Verikas, Dovydas, Matuliauskas, Dovydas, Platūkis, Tautvydas, Vaičiulienė, Dovilė, Jurgaitytė, Julija, Kupstytė‐Krištaponė, Nora, Dirsienė, Rūta, Jaruševičius, Gediminas, Šakalytė, Gintarė, Plisienė, Jurgita, Lesauskaitė, Vaiva

“…Aims This study sought to examine the feasibility, accuracy and reproducibility of a novel, fully automated 2D transthoracic echocardiography (2D TTE)…”
Get full text

Factors Determining Ticagrelor-Induced Dyspnea in Patients with Acute Coronary Syndrome by Tamakauskas, Vytenis, Žaliūnas, Remigijus, Lesauskaitė, Vaiva, Kupstytė-Krištaponė, Nora, Šakalytė, Gintarė, Jurgaitytė, Julija, Čiapienė, Ieva, Tatarūnas, Vacis

“…(1) Background: The aim of this study was to determine clinical and genetic factors predicting the development of dyspnea in patients receiving ticagrelor. (2)…”
Get full text

The Effect of Platelet Activity, ABCB1 Genetic Polymorphism, and Renal Function on the Development of Ticagrelor-Related Dyspnea in Patients with Acute Coronary Syndrome by Tamakauskas, Vytenis, Žaliūnas, Remigijus, Lesauskaitė, Vaiva, Kupstytė-Krištaponė, Nora, Čiapienė, Ieva, Šakalytė, Gintarė, Plisienė, Jurgita, Skipskis, Vilius, Tatarūnas, Vacis

“…The aim of this study was to determine the effect of genetic polymorphism and renal function on the occurrence of ticagrelor-related dyspnea. A total of 299…”
Get full text

Enterobacterales Biofilm-Specific Genes and Antimicrobial and Anti-Inflammatory Biomarkers in the Blood of Patients with Ischemic Heart Disease by Giedraitiene, Agne, Tatarunas, Vacis, Kaminskaite, Kornelija, Meskauskaite, Ugne, Boieva, Svitlana, Ajima, Yu, Ciapiene, Ieva, Veikutiene, Audrone, Zvikas, Vaidotas, Kupstyte-Kristapone, Nora, Jakstas, Valdas, Luksiene, Dalia, Tamosiunas, Abdonas, Lesauskaite, Vaiva

“…Ischemic heart disease (IHD) is the most prevalent type of cardiovascular disease. The main cause of IHD is atherosclerosis, which is a multifactorial…”
Get full text

Bedside stratification of patients according to CYP2C192 genotype by Karaliūtė, Rasa, Gustienė, Olivija, Kupstytė, Nora, Ambrasienė, Daiva, Tatarūnas, Vacis

“…Objective. The task was to identify the defective CYP2C19*2 allele by using a novel fast-genotyping method in the patients having coronary artery disease who…”
Get full text

Factors associated with platelet reactivity during dual antiplatelet therapy in patients with diabetes after acute coronary syndrome by Tatarunas, Vacis, Kupstyte-Kristapone, Nora, Zvikas, Vaidotas, Jakstas, Valdas, Zaliunas, Remigijus, Lesauskaite, Vaiva

“…Antiplatelet drugs are prescribed without considering the diabetic status of the patient. The objective of the current investigation was to determine the…”
Get full text

Prognostication of long-term outcomes for patients with ischemic heart disease by Umbrasienė, Jelena, Jankauskienė, Edita, Kupstytė, Nora, Babarskienė, Marija Rūta, Venclovienė, Jonė, Gustienė, Olivija

“…Cardiovascular disease, including coronary heart disease (CHD), is the leading cause of death among elderly adults across many European countries. In 2005, the…”
Get full text

The impact of clinical and genetic factors on ticagrelor and clopidogrel antiplatelet therapy by Tatarunas, Vacis, Kupstyte, Nora, Zaliunas, Remigijus, Giedraitiene, Agne, Lesauskaite, Vaiva

“…To determine clinically significant factors which may alter the effect of dual antiplatelet therapy with aspirin and ticagrelor or clopidogrel in patients who…”
Get full text

ŠIrdies Vainikinių Arterijų Kalcinozės, Trombozės ir Ankstyvosios Stentų Trombozės Klinikinių ir Genetinių Prognozės Veiksnių Paieška by Kupstytė, Nora

“…Pasaulio Sveikatos Organizacijos (Pso) Duomenimis, Sergamumas Ir Mirtingumas Nuo Širdies Ir Kraujagyslių Ligų (Škl) Yra Didžiausias Ekonomiškai Išsivysčiusių…”
Get full text

The impact of CYP2C192, CYP4F23, and clinical factors on platelet aggregation, CYP4F2 enzyme activity, and 20-hydroxyeicosatetraenoic acid concentration in patients treated with dual antiplatelet therapy by Tatarunas, Vacis, Kupstyte, Nora, Giedraitiene, Agne, Skipskis, Vilius, Jakstas, Valdas, Zvikas, Vaidotas, Lesauskaite, Vaiva

“…The aim of the current study was to evaluate the impact of CYP2C192 (rs4244285), CYP4F23 (rs2108622), and nongenetic factors on platelet aggregation and to…”
Get full text

The impact of CYP2C19 2, CYP4F2 3, and clinical factors on platelet aggregation, CYP4F2 enzyme activity, and 20-hydroxyeicosatetraenoic acid concentration in patients treated with dual antiplatelet therapy by Tatarunas, Vacis, Kupstyte, Nora, Giedraitiene, Agne, Skipskis, Vilius, Jakstas, Valdas, Zvikas, Vaidotas, Lesauskaite, Vaiva

Get full text

The role of clinical parameters and of CYP2C19 G681 and CYP4F2 G1347A polymorphisms on platelet reactivity during dual antiplatelet therapy by Tatarunas, Vacis, Jankauskiene, Laima, Kupstyte, Nora, Skipskis, Vilius, Gustiene, Olivija, Grybauskas, Pranas, Lesauskaite, Vaiva

“…Dual antiplatelet therapy with aspirin and clopidogrel is used to lower the risk of arterial thrombosis. However, this strategy is not always successful owing…”
Get full text

The Effect of PAI-1 4G/5G Polymorphism and Clinical Factors on Coronary Artery Occlusion in Myocardial Infarction by Zaliaduonyte-Peksiene, Diana, Kupstyte, Nora, Skipskis, Vilius, Tatarunas, Vacis, Parpugga, Tajinder Kumar, Lesauskaite, Vaiva

“…Objective. Data on the impact of PAI-1-675 4G/5G genotype for fibrinolysis during myocardial infarction are inconsistent. The aim of our study was to evaluate…”
Get full text

Effect of clinical factors and gene polymorphism of by Kupstyte, Nora, Zaliunas, Remigijus, Tatarunas, Vacis, Skipskis, Vilius, Zaliaduonyte-Peksiene, Diana, Grabauskyte, Ingrida, Dovidaitiene, Dovile, Bumblauskas, Karolis, Gustiene, Olivija, Lesauskaite, Vaiva

“…To determine the main clinical and genetic factors having impact on early coronary stent thrombosis. Genotyping of , and in patients with (n = 31) and without…”
Get full text

Effect of clinical factors and gene polymorphism of CYP2C192, 17 and CYP4F23 on early stent thrombosis by Kupstyte, Nora, Zaliunas, Remigijus, Tatarunas, Vacis, Skipskis, Vilius, Zaliaduonyte-Peksiene, Diana, Grabauskyte, Ingrida, Dovidaitiene, Dovile, Bumblauskas, Karolis, Gustiene, Olivija, Lesauskaite, Vaiva

“…To determine the main clinical and genetic factors having impact on early coronary stent thrombosis. Genotyping of CYP2C19*2, *17 and CYP4F2*3 in patients with…”
Get full text

The Effect of Platelet Activity, ABCBI Genetic Polymorphism, and Renal Function on the Development of Ticagrelor-Related Dyspnea in Patients with Acute Coronary Syndrome by Tamakauskas, Vytenis, Zaliunas, Remigijus, Lesauskaite, Vaiva, Kupstyte-Kristapone, Nora, Ciapiene, Leva, Sakalyte, Gintare, Plisiene, Jurgita, Skipskis, Vilius, Tatarunas, Vacis

“…Purpose: The aim of this study was to determine the effect of ABCBI genetic polymorphism and renal function on the occurrence of ticagrelor-related dyspnea…”
Get full text

The impact of CYP2C19 and CYP4F2 variants and clinical factors on treatment outcomes during antiplatelet therapy by Tatarunas, Vacis, Kupstyte-Kristapone, Nora, Norvilaite, Rita, Tamakauskas, Vytenis, Skipskis, Vilius, Audrone, Veikutiene, Jurgaityte, Julija, Stuoka, Mantvydas, Lesauskaite, Vaiva

“…The aim of this study was to determine the impact of genetic and nongenetic factors on treatment outcomes in patients receiving dual antiplatelet therapy after…”
Get full text

IEnterobacterales/I Biofilm-Specific Genes and Antimicrobial and Anti-Inflammatory Biomarkers in the Blood of Patients with Ischemic Heart Disease by Giedraitiene, Agne, Tatarunas, Vacis, Kaminskaite, Kornelija, Meskauskaite, Ugne, Boieva, Svitlana, Ajima, Yu, Ciapiene, Ieva, Veikutiene, Audrone, Zvikas, Vaidotas, Kupstyte-Kristapone, Nora, Jakstas, Valdas, Luksiene, Dalia, Tamosiunas, Abdonas, Lesauskaite, Vaiva

“…Background: Ischemic heart disease (IHD) is the most prevalent type of cardiovascular disease. The main cause of IHD is atherosclerosis, which is a…”
Get full text